209 related articles for article (PubMed ID: 8556761)
21. Absence of increased height velocity in the first year of life in untreated children with simple virilizing congenital adrenal hyperplasia.
Claahsen-van der Grinten HL; Noordam K; Borm GF; Otten BJ
J Clin Endocrinol Metab; 2006 Apr; 91(4):1205-9. PubMed ID: 16464952
[TBL] [Abstract][Full Text] [Related]
22. Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Results of a multicenter study.
Hargitai G; Sólyom J; Battelino T; Lebl J; Pribilincová Z; Hauspie R; Kovács J; Waldhauser F; Frisch H;
Horm Res; 2001; 55(4):161-71. PubMed ID: 11598369
[TBL] [Abstract][Full Text] [Related]
23. Final height of patients with classical congenital adrenal hyperplasia.
Aycan Z; Akbuğa S; Cetinkaya E; Ocal G; Berberoğlu M; Evliyaoğlu O; Adiyaman P
Turk J Pediatr; 2009; 51(6):539-44. PubMed ID: 20196386
[TBL] [Abstract][Full Text] [Related]
24. Overestimation of final height prediction in patients with classical congenital adrenal hyperplasia using the Bayley and Pinneau method.
Bonfig W; Schwarz HP
J Pediatr Endocrinol Metab; 2012; 25(7-8):645-9. PubMed ID: 23155688
[TBL] [Abstract][Full Text] [Related]
25. Growth in disorders of adrenal hyperfunction.
Savage MO; Scommegna S; Carroll PV; Ho JT; Monson JP; Besser GM; Grossman AB
Horm Res; 2002; 58 Suppl 1():39-43. PubMed ID: 12373013
[TBL] [Abstract][Full Text] [Related]
26. Long-term Growth in Congenital Adrenal Hyperplasia.
Maheshwari A; Khadilkar V; Gangodkar P; Khadilkar A
Indian J Pediatr; 2019 Feb; 86(2):154-158. PubMed ID: 30097840
[TBL] [Abstract][Full Text] [Related]
27. Growth in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Dörr HG
Horm Res; 2007; 68 Suppl 5():93-9. PubMed ID: 18174719
[TBL] [Abstract][Full Text] [Related]
28. Growth of patients with 21-hydroxylase deficiency: an analysis of the factors influencing adult height.
Jääskeläinen J; Voutilainen R
Pediatr Res; 1997 Jan; 41(1):30-3. PubMed ID: 8979286
[TBL] [Abstract][Full Text] [Related]
29. Absence of clinically relevant growth acceleration in untreated children with non-classical congenital adrenal hyperplasia.
Pijnenburg-Kleizen KJ; Borm GF; Otten BJ; Schott DA; van den Akker EL; Stokvis-Brantsma WH; Voorhoeve PG; Bakker B; Claahsen-van der Grinten HL
Horm Res Paediatr; 2012; 77(3):164-9. PubMed ID: 22508177
[TBL] [Abstract][Full Text] [Related]
30. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty.
Bonfig W; Bechtold S; Schmidt H; Knorr D; Schwarz HP
J Clin Endocrinol Metab; 2007 May; 92(5):1635-9. PubMed ID: 17299071
[TBL] [Abstract][Full Text] [Related]
31. [The analysis of psychological and social problems, the physical development in young people with congenital adrenal hyperplasia - owner experience].
Barg E; Marczyk T; Wirth M; Spera A; Wiszniowska M; Drożdż A
Pediatr Endocrinol Diabetes Metab; 2010; 16(4):238-48. PubMed ID: 21447264
[TBL] [Abstract][Full Text] [Related]
32. Growth pattern during the first 36 months of life in congenital adrenal hyperplasia (21-hydroxylase deficiency).
Gasparini N; Di Maio S; Salerno M; Argenziano A; Franzese A; Tenore A
Horm Res; 1997; 47(1):17-22. PubMed ID: 9010713
[TBL] [Abstract][Full Text] [Related]
33. Congenital adrenal hyperplasia: lessons from a multinational study.
Frisch H; Waldhauser F; Lebl J; Solyom J; Hargitai G; Kovacs J; Pribilincova Z; Krzisnik C; Battelino T;
Horm Res; 2002; 57 Suppl 2():95-101. PubMed ID: 12065936
[TBL] [Abstract][Full Text] [Related]
34. Late adolescent linear growth pattern in pediatric-onset inflammatory bowel disease.
Hood HC; Cohen LE; Lee JJ
J Pediatr Gastroenterol Nutr; 2011 Sep; 53(3):246-9. PubMed ID: 21865969
[TBL] [Abstract][Full Text] [Related]
35. Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome.
Manoli I; Kanaka-Gantenbein Ch; Voutetakis A; Maniati-Christidi M; Dacou-Voutetakis C
Clin Endocrinol (Oxf); 2002 Nov; 57(5):669-76. PubMed ID: 12390343
[TBL] [Abstract][Full Text] [Related]
36. Experience with long-term glucocorticoid treatment in congenital adrenal hyperplasia: growth pattern compared with genetic height potential.
Aycan Z; Ocal G; Berberoglu M; Cetinkaya E; Adiyaman P; Evliyaoglu O
J Pediatr Endocrinol Metab; 2006 Mar; 19(3):245-51. PubMed ID: 16607925
[TBL] [Abstract][Full Text] [Related]
37. Growth inhibition by glucocorticoid treatment in salt wasting 21-hydroxylase deficiency: in early infancy and (pre)puberty.
Stikkelbroeck NM; Van't Hof-Grootenboer BA; Hermus AR; Otten BJ; Van't Hof MA
J Clin Endocrinol Metab; 2003 Aug; 88(8):3525-30. PubMed ID: 12915631
[TBL] [Abstract][Full Text] [Related]
38. Long-term follow-up of children with classic congenital adrenal hyperplasia: suggestions for age dependent treatment in childhood and puberty.
Pijnenburg-Kleizen KJ; Thomas CMG; Otten BJ; Roeleveld N; Claahsen-van der Grinten HL
J Pediatr Endocrinol Metab; 2019 Oct; 32(10):1055-1063. PubMed ID: 31573958
[TBL] [Abstract][Full Text] [Related]
39. [Differential diagnosis in children with small stature].
Lebl J; Zemková D; Kolousková S; Snajderová M
Cas Lek Cesk; 1995 Mar; 134(6):166-9. PubMed ID: 7758066
[TBL] [Abstract][Full Text] [Related]
40. [Longitudinal data of physical growth of healthy children. V. Acromial, radial, styleoideal, daktylion, ileospinal, tibial and medial malleolus heights of children aged 2.5 to 15 years (author's transl)].
Reinken L; Stolley H; Droese W; van Oost G
Klin Padiatr; 1980 Nov; 192(6):559-64. PubMed ID: 7194398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
